Emcure Pharma gets two observations in Form 483 for API plant from USFDA
[ad_1] New DelhiEmcure Pharmaceuticals on Wednesday said the US health regulator has issued two observations after inspecting its Pune-based active pharmaceutical ingredients (API) manufacturing facility.The US Food and Drug Administration…